Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) Cost of Revenue (2020 - 2025)

Bio Essence (BIOE) has 6 years of Cost of Revenue data on record, last reported at -$61487.0 in Q3 2025.

  • For Q3 2025, Cost of Revenue fell 234.58% year-over-year to -$61487.0; the TTM value through Sep 2025 reached $71250.0, down 9.44%, while the annual FY2024 figure was $106863.0, 137.1% up from the prior year.
  • Cost of Revenue reached -$61487.0 in Q3 2025 per BIOE's latest filing, down from $91537.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $235958.0 in Q1 2022 and bottomed at -$395973.0 in Q4 2022.
  • Average Cost of Revenue over 5 years is $9066.8, with a median of $18410.0 recorded in 2021.
  • Peak YoY movement for Cost of Revenue: skyrocketed 1420.05% in 2022, then crashed 1534.37% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $151315.0 in 2021, then plummeted by 361.69% to -$395973.0 in 2022, then soared by 103.15% to $12475.0 in 2023, then skyrocketed by 225.91% to $40657.0 in 2024, then plummeted by 251.23% to -$61487.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were -$61487.0 in Q3 2025, $91537.0 in Q2 2025, and $543.0 in Q1 2025.